Healthcare exit advisors

Healthcare owners need advisers who understand that the buyer is not just acquiring earnings. They are also acquiring regulatory exposure, clinical or service delivery risk, staffing resilience, reputation and the continuity of care. In some cases the business is a regulated practice; in others it is a services company with strong recurring relationships but a high duty of care. Those differences matter, because the right exit process depends on what a buyer will actually scrutinise.

The strongest public matches in this directory are not all pure healthcare boutiques. Brabners, Hawsons Corporate Finance, Shaw & Co, Bishopsgate Corporate Finance, Arrowpoint Advisory and Burges Salmon all show relevant healthcare, medical or adjacent services work. That is useful because healthcare exits often sit at the intersection of legal, tax, valuation and corporate finance rather than one narrow discipline. The best adviser team can help the owner understand which issues are commercial, which are compliance-led and which simply need tidying before a buyer sees them.

For owners of medical, care, diagnostics, specialist services or healthcare-adjacent businesses, sector experience is most valuable when it is specific. A team that has handled hospitals, practices, care services or healthcare suppliers will understand how clients are won, how contracts renew, how people risk flows through the P&L and which representations tend to matter in diligence. It is not enough for a firm to be generally good at M&A; it should be able to show it has worked through the real issues that decide whether a healthcare deal gets done cleanly.

Another reason healthcare pages are useful is that many owners are exploring more than one exit route. A trade sale may be the obvious option, but a management buyout or staged succession can be more attractive when the team is stable and the founder wants continuity. The adviser shortlist should therefore be judged against the outcome the owner actually wants, not against a generic “sell the business” brief.

When comparing firms, look for evidence of deal process discipline, comfort with regulated or sensitive information, and the ability to keep the timetable tight without creating unnecessary alarm. The public profile should make clear whether the firm is working on mainstream healthcare M&A, professional-medical practices or healthcare-adjacent services, because those are not the same thing.

The profiles below are the useful starting point. Once you have compared them, move on to the route pages to see whether a trade sale, MBO or succession plan fits the business model and the owner’s timing.